This web site uses cookies to deliver its users personalized dynamic content. You are hereby informed that cookies are necessary for the web site's functioning and that by continuing to use this web sites, cookies will be used in cooperation with your Web browser.
The purpose of this study is to define the effect of 4 week monotherapy with with an oral antagonistof cysteinyl leukotriene receptors (CysLT1) montelukast on the secretion of regulatory cytokines, IL-10 and TGF-beta, bronchial hyperresponsiveness and clinical parameters in atopic asthma children. The methods used will enable us to investigate which cell subset is a target for a possible effect of montelukast on the regulation of these immunoregulatory cytokines.
Short description of the task performed by Croatian partner